Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expansion and improving operating metrics. The brokerage expects revenue, EBITDA and PAT to grow at CAGRs of 19.5%, 25% and 33%, respectively, through FY28.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
